Abstract: Dimedone is a widely used reagent to assess the redox state of cysteine-containing proteins as it will alkylate sulfenic acid residues, but not sulfinic acid residues. While it has been reported that dimedone can label selenenic acid residues in selenoproteins, we investigated the stability, and reversibility of this label in a model peptide system. We also wondered whether dimedone could be used to detect seleninic acid residues. We used benzenesulfinic acid, benzeneseleninic acid, and model selenocysteine-containing peptides to investigate possible reactions with dimedone. These peptides were incubated with H 2 O 2 in the presence of dimedone and then the reactions were followed by liquid chromatography/electrospray ionization mass spectrometry (LC/ ESI-MS). The native peptide, H-PTVTGCUG-OH (corresponding to the native amino acid sequence of the C-terminus of mammalian thioredoxin reductase), could not be alkylated by dimedone, but could be carboxymethylated with iodoacetic acid. However the "mutant peptide," H-PTVTGAUG-OH, could be labeled with dimedone at low concentrations of H 2 O 2 , but the reaction was reversible by addition of thiol. Due to the reversible nature of this alkylation, we conclude that dimedone is not a good reagent for detecting selenenic acids in selenoproteins. At high concentrations of H 2 O 2 , selenium was eliminated from the peptide and a dimeric form of dimedone could be detected using LCMS and 1 H NMR. The dimeric dimedone product forms as a result of a seleno-Pummerer reaction with Sec-seleninic acid. Overall our results show that the reaction of dimedone with oxidized cysteine residues is quite different from the same reaction with oxidized selenocysteine residues.
Introduction
Most selenoproteins characterized to date are oxidoreductases that utilize thiol/disulfide exchange reactions to catalyze specific reactions. 1 In addition, many selenoproteins have been shown to have peroxidase activity. This peroxidase activity is due to the "Janus-faced" nature of selenium 2 ; the highly nucleophilic selenolate of selenocysteine (Sec) is readily oxidized by hydrogen peroxide (H 2 O 2 ) to form a Sec-selenenic acid, which is strongly electrophilic. Sec-selenenic acid is then either rapidly reduced by resolving enzymic cysteine (Cys) residues, or by exogenous thiols like glutathione (GSH).
1 Dimedone (5,5-dimethylcyclohexane-1,3-dione), a small molecule 1,3-diketone, is frequently used to detect protein sulfenic acids, as dimedone will alkylate Cys-sulfenic acids forming a stable adduct that can be detected by mass spectrometry. 3 It has also found use in labeling Sec-selenenic acids of selenoproteins. 4, 5 However, in the case of selenoprotein S, the selenenic acid could only be alkylated when a resolving Cys residue was mutated to serine (Ser), otherwise rapid formation of a selenosulfide bond prevented alkylation of the selenenic acid with dimedone. 4 Mammalian thioredoxin reductase (mTrxR) is a selenoenzyme whose primary catalytic function is to reduce the oxidized form of thioredoxin (Trx), a small dithiol-containing protein that serves to maintain cellular redox homeostasis. 6 The enzyme also has weak peroxidase activity due to the presence of Sec as discussed above. 7 Presumably, this peroxidase activity is due to the reaction of the Sec-selenolate with H 2 O 2 to form a Sec-selenenic acid, which can then be resolved by an adjacent Cys residue to form a selenosulfide bond as shown in Figure 1(A) . If the lifetime of the Sec-selenenic acid is long enough it could theoretically be alkylated by dimedone [ Fig.  1(B) ], causing inhibition of the enzyme. Similar to the study done with selenoprotein S, we also were unable to use dimedone to alkylate the selenenic acid of wild type mTrxR as shown by the absence of inhibition of the enzyme in the presence of dimedone. 4, 8 As in the case of selenoprotein S, the lack of alkylation by dimedone could be due to rapid resolution of the Sec-selenenic acid by the adjacent, resolving Cys residue [ Fig. 2(A) ], but other possibilities exist as well. These other possibilities are: (i) the Sec-selenenic acid is alkylated by dimedone, but the alkylation is rapidly reversed by the resolving Cys residue [ Fig. 2 (B)], and (ii) the Sec residue is over oxidized to a Sec-seleninic acid (Sec-SeO . If the reactivity of Sec-seleninic acid is identical to Cys-sulfinic acid, then it is expected that dimedone would be unreactive toward Sec-seleninic acid and alkylation would not occur. However, the reactivity of seleninic acid with dimedone is heretofore unknown
In this study, we explored these three options by studying the reaction of dimedone with model peptides that correspond to the C-terminal tail of mTrxR, which contains the Sec residue. We found that the peptide H-PTVTGCUG-OH, containing the adjacent, resolving Cys residue, could not be alkylated with 
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The Use of Dimedone to Study Selenoproteins dimedone. We were, on the other hand, able to alkylate a "mutant" peptide (H-PTVTGAUG-OH) with dimedone in which the resolving Cys residue was replaced with alanine (Ala). However, this alkylation could be reversed by addition of reducing agents such as b-mercaptoethanol (bME) and tris(2-carboxyethyl)-phosphine (TCEP) . Surprisingly, dimedone alkylation could also be reversed by adding disulfides such as hydroxyethyldisulfide and cystine to the alkylated peptide. The diselenide-containing compound selenocystine also reversed dimedone alkylation.
An important finding of this study is that dimedone reacts with Sec-seleninic acid, unlike the corresponding reaction of dimedone and Cys-sulfinic acid. Reaction of dimedone with model seleninic acids resulted in formation of diselenides and a dimedone dimer as a result of a seleno-Pummerer reaction. [10] [11] [12] [13] We were able to detect this dimeric form of dimedone when higher concentrations of H 2 O 2 were used to oxidize the mutant peptide, H-PTVTGAUG-OH, in the presence of dimedone. This result may lead to the development of a method to detect Sec-seleninic acid, a highly transient species, in selenoproteins.
Results

Attempt to inhibit thioredoxin reductase by dimedone treatment in presence of H 2 O 2
To address the question of whether the adjacent Cys residue of mTrxR-GCUG interferes with alkylation of Sec-selenenic acid by dimedone, we constructed a mutant enzyme in which the adjacent Cys residue was replaced by Gly (mTrxR-GGUG). Both the wild type enzyme, mTrxR-GCUG, and mutant enzyme, mTrxR-GGUG, were subjected to a selenocystine reductase assay, which measures each enzyme's ability to reduce selenocystine after exposure to H 2 O 2 and dimedone.
14 In this assay, the % selenocystine reductase activity remaining of each enzyme after exposure to H 2 O 2 and dimedone is indicative of how much Sec-selenenic acid is being alkylated by dimedone. The results from this experiment are shown in Table I . The data show that the wild type mTrxR-GCUG enzyme retained full selenocystine reductase activity, which is identical to our previous result. 8 However, the mutant mTrxR-GGUG enzyme retained only 74% of selenocystine reductase activity after being exposed to H 2 O 2 and dimedone. We interpret this result as the Sec-selenenic acid of the mutant enzyme mTrxR-GGUG being alkylated with dimedone, causing inhibition of selenocystine reductase activity. In this case, the Sec-selenenic acid of the mutant enzyme could be alkylated because there was no resolution of Sec-selenenic acid by the adjacent Cys residue. We believe the reason for the lack of complete inhibition of the mutant enzyme by dimedone is due to the presence of the N-terminal redox center of the enzyme, which contains two redox active Cys residues that may be able to reverse the alkylation.
Labeling of model Sec-containing peptides with dimedone
The peptides that we chose to synthesize were based on the C-terminal amino acid sequence of mTrxR. We either synthesized the wild type peptide, H-PTVTGCUG-OH, or mutant peptide, H-PTVTGAUG-OH. In the case of the mutant peptide, the antepenultimate Cys residue has been mutated to Ala to avoid resolution of Sec-selenenic acid, as would occur if the adjacent Cys was present in the peptide, resulting in the formation of a selenosulfide bond [ Fig. 1(A) ].
First, we performed a control experiment with the oxidized, wild type peptide. We reduced the wild type peptide with a 10-fold excess of TCEP and subsequently alkylated it with iodoacetic acid. The results showed that both the Cys and Sec residue of the peptide could be carboxymethylated (Fig. S1 of the Supporting Information). However in a similar experiment, we were unable to alkylate the wild type peptide with either 50 lM dimedone (10-fold excess) or 500 lM dimedone (100-fold excess) in the presence of H 2 O 2 , identical to our results with the full-length enzyme (Figs. S2 and S3 of the Supporting Information). The fact that we were able to dialkylate the peptide with iodoacetic acid shows that we were able to effectively reduce the selenosulfide bond with TCEP, making both the sulfur and selenium susceptible to oxidation by H 2 O 2 and subsequent labeling by dimedone. The lack of dimedone alkylation shows that it must be the specific Se-C bond of the Sec-dimedone adduct that is labile for the reasons we discuss in Figure 2 , as the carboxymethylation of Sec by iodoacetic acid was not reversed by the resolving Cys residue.
A difficulty in our experimental design with the mutant peptide that had to be overcome was the generation of free Sec-selenol. Alkyl selenols do not exist in solution for a long duration 15 due to their tendency to oxidize to the diselenide form. 16 To mitigate this problem, we utilized a strategic protecting group, 5-Npys, on Sec, that allowed us to rapidly generate Sec-selenol in situ, which could be further oxidized to Sec-selenenic acid by H 2 O 2 and alkylated with dimedone as shown in Figure 3 . The selenosulfide bond between the selenium of Sec and the sulfur of the 5-Npys group is readily cleaved by ascorbate, generating dehydroascorbic acid in the process. 15 Therefore, before oxidizing the Sec peptide in the presence of dimedone, the relevant selenol form of Sec was generated by incubating the 5-Npysprotected Sec-peptide with ascorbate. This approach does not depend on the use of an exogenous thiol to generate the selenol. The presence of exogenous thiol would have greatly complicated the interpretation of the results, as the added thiol could potentially reverse alkylation of Sec by dimedone.
The results of our attempts to alkylate the Secselenenic acid of peptide H-PTVTGAUG-OH with dimedone are displayed in Figure 4 . The extracted ion chromatogram in Figure 4 (A) shows that the vast majority of peptide H-PTVTGAUG-OH is oxidized to the Sec-selenenic acid and subsequently alkylated with dimedone. Peptide that was not labeled was oxidized to the diselenide, which is the product of the disproportionation of two selenenic acids. 16 Thus, the 10-fold excess of dimedone relative to peptide used in the experiment was sufficient for the alkylation reaction to outcompete disproportionation. We note that, in both cases, the mass spectra shown in Figure 4 (B and C) clearly display the characteristic isotope pattern of selenium-containing peptides, which dispels any doubt that the signal corresponding to the dimedone-alkylated H-PTVTGAUG-OH is artifactual.
Demonstrating the lability of the Sec-dimedone label
After successfully alkylating the Sec-selenenic acid of peptide H-PTVTGAUG-OH with dimedone, we desired to address the question raised in Figure  2 (B), that is, could the reason why the wild type form of mTrxR retains peroxidase activity even in the presence of dimedone be due to the fact that the dimedone label is being removed by the adjacent, resolving Cys residue? To address this question, we subjected mutant peptide H-PTVTGAUG-OH to the 
PROTEINSCIENCE.ORG
The Use of Dimedone to Study Selenoproteins same conditions used to alkylate the Sec-selenenic acid with dimedone, then immediately incubated the alkylated peptide with 10-fold molar excesses of bME or TCEP for 15 min. Figure 5 shows the results from these experiments, which demonstrate that under all reducing conditions employed, the Sec-dimedone label is labile. In the case of 103 bME, more than half of the dimedone label was removed and the peptide was detected as the bME adduct (Fig. 5 ). When 103 TCEP was used as the reducing agent, 50-60% of the label was also removed. The peptide was detected in the reduced form (Fig. 5 ), but the TCEP adduct was not detected. When 10003 bME was used, no dimedone-labeled peptide H-PTVTGAUG-OH was detected and only the bME adduct was observed (data not shown). For comparison, experiments conducted by Carroll et al.
showed that the Cys-dimedone label of a model dipeptide was stable over 12 h to similar reducing conditions of 10-fold molar excesses of dithiothreitol (DTT), glutathione (GSH), or TCEP. 17 To further validate our experiment showing that addition of bME results in removal of the dimedone label, we did a control experiment in which hydroxyethyl disulfide was added instead. To our surprise, addition of this disulfide also resulted in removal of the dimedone label (data not shown). We then repeated this experiment using the more relevant disulfide compound cystine instead, and this disulfide also resulted in removal of the dimedone label and formation of a cysteinyl-peptide adduct. We reasoned that addition of a diselenide should enhance removal of the dimedone label, so selenocystine was added as a removal agent. Indeed, we found that addition of the diselenide enhanced the amount of dimedone label removed from the peptide (see the bottom two panels of Fig. 5 ).
Reaction of dimedone with model seleninic acids
The reactivity of dimedone toward seleninic acids has not been reported in the literature so far as we are aware. While we showed that one possible reason mTrxR is not inhibited by dimedone in the presence of H 2 O 2 is due to the removal of the Secdimedone adduct by thiols [ Fig. 2(B) ], the question raised in Figure 2 (C) still remained unaddressed, could dimedone be reacting with a Sec-seleninic acid? We hypothesized that dimedone would react with seleninic acids because of their high Se-electrophilicity. Seleninic acids, unlike sulfinic acids, are highly electrophilic and can be rapidly reduced by thiols and other reducing agents. 2 The reactivity of dimedone toward seleninic acids was first explored in a qualitative, model experiment, where a solution of 100 mM PhSeO 2 H and 200 mM dimedone was prepared in methanol. After approximately 15 min, the solution turned from clear, colorless to an intense yellow color, indicating a reaction between the two compounds. The observation of this yellow color led us to hypothesize that one product of the reaction could be diphenyl diselenide, which has a yellow color in solution.
In order to further test this hypothesis, we employed a 77 Se NMR time course experiment where the reaction between PhSeO 2 H and dimedone in CD 3 OD was followed for 6 h in 3 h intervals. The results from this experiment are shown in Figure 6 . As shown in the figure, a resonance at d 5 463 ppm appeared within 3 h of reaction time and remained the only observable resonance after 6 h. A control 77 Se NMR spectrum of the pure compound confirmed that this resonance corresponds to diphenyl diselenide, which further supports our hypothesis that dimedone is indeed reducing PhSeO 2 H (12 Se NMR spectrum of diphenyl diselenide. Next, in order to show that dimedone would react not only with aromatic seleninic acids, but also with alkyl seleninic acids such as Sec, we monitored the reaction of commercially available MeSeO 2 H with dimedone in CD 3 OD using the same 77 Se NMR time course experiment.
As shown in Figure 7 , dimedone quantitatively reduces MeSeO 2 H to dimethyl diselenide (d 5 263 ppm) after only 30 min of reaction time (see Fig. S5 of the Supporting Information for the control 77 Se NMR spectrum of dimethyl diselenide). As a control, the reactivity of dimedone toward benzenesulfinic acid (PhSO 2 H), the sulfur-containing analog of PhSeO 2 H, was explored in a 1 H NMR time course experiment (see Fig. S6 of the Supporting Information). As expected, there was no observable reaction between dimedone and PhSO 2 H even after 7 days of reaction time. Furthermore, since PhSeO 2 H is a weak acid (pK a is 4.79), we conducted a control experiment designed to show that dimedone was, in fact, undergoing a redox reaction with the model seleninic acids, and not just an acidbase reaction. 18 The reactivity of dimedone in acidic media generated by p-toluenesulfonic acid (p-TsOH) was determined in a similar 1 2), respectively. The lability of the Sec-dimedone label is demonstrated by the cases where reducing agent was added (bME and TCEP), which resulted in the amount of dimedone-labeled H-PTVTGAUG-OH decreasing substantially with a corresponding increase in the amount of peptide-bME adduct and/or peptide in the reduced, selenol form. The lability of the Sec-dimedone label is further demonstrated by the removal of the dimedone label upon exposure to disulfide (cystine) or diselenide (selenocystine) compounds, both of which are expected to be chemically inert to alkyl selenides. Addition of cystine results in the formation of a cysteinyl-peptide adduct, while addition of selenocystine results in the formation of a selenocysteinyl-peptide adduct.
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The Use of Dimedone to Study Selenoproteins resonances, slightly downfield of the original resonances, were observed during the time course, and these resonances were not informative. Despite this result, we hypothesized that the seleninic acids were undergoing a variation of the Pummerer reaction, as shown in Figure 8 . [10] [11] [12] [13] This hypothesis was based on the fact that the seleninic acid was being reduced to the diselenide, which means that dimedone must be oxidized during the reaction. In the first step of the proposed mechanism, the nucleophilic carbon atom of dimedone In order to verify our hypothesis that 1a is a product of our proposed seleno-Pummerer reaction, we subjected an aliquot of the reaction between dimedone and PhSeO 2 H for high performance liquid chromatography-mass spectrometry (LCMS) analysis. Figure 9 (A) displays the HPLC total ion current (TIC) of the reaction mixture, which shows the elution of two analytes with retention times of 18.3 min and 26.7 min, respectively. The resulting mass spectra obtained from the eluted analyte at t 5 18.3 min is shown in Figure 9 (B). The spectrum shows a peak at m/z 5 277.2, which was identified as the [M 1 H] 1 ion of 1a. In addition, the observation of a more intense peak at m/z 5 309.3, an increase of 32 Da, supports the existence of 1a as this mass corresponds to the methanol adduct (1b). The alkene center of 1a is highly electrophilic and is unstable in nucleophilic solvents. As a result, 1a could not be isolated through employment of standard chromatographic conditions on SiO 2 , a result likely attributable to the highly electrophilic character of this alkene.
The mass spectrum obtained from the analyte observed at t 5 26.7 min is shown in Figure 9 (C). It shows only one main ion at m/z 5 303.4, which we attribute to the [M 1 H] 1 ion of the condensation product between two dimedone molecules and acetone (2). 20 Acetone could be present due to either breakdown of dimedone during the reaction or contamination of the reaction glassware. Purification of 2 on SiO 2 yielded 1 H, 13 C{1H}, and 13 C-DEPT135
NMR spectra, as well as elemental analysis data that matched the compound (see Figs. S10-S14 of the Supporting Information for characterization data of 2). One can envision a mechanism to produce 2 without direct redox interaction with the selenium atom of a seleninic acid. As 2 is the minor product of the reaction [see Fig. 9 (A)], it was of little significance to this study.
The presence of 1a as a chemical signature of seleninic acid in a model peptide
Recently a molecular probe was developed to detect protein Cys-sulfinic acids, the sulfur-containing analog of Sec-seleninic acids. 21 However, no similar chemical probe is known to detect the presence of Sec-seleninic acid. Our findings detailed above led us to pursue the use of 1a as a chemical footprint for the detection of Sec-seleninic acid. We envisioned an assay in which a Sec-containing peptide or protein would be exposed to H 2 O 2 in the presence of dimedone. This could potentially generate a Secseleninic acid in situ that could react with dimedone to produce 1a, which could then be detected by a LCMS experiment similar to the one presented in Figure 9 .
To this end, we conducted an experiment where our model Sec-peptide, H-PTVTGAUG-OH, was exposed to a 5-molar excess of H 2 O 2 while incubated with a 2-molar excess of dimedone. The result from this experiment is shown in the top panel of Figure  10 . The extracted ion chromatogram shows that, under these conditions, 1a was produced from dimedone's reaction with the Sec-seleninic acid of peptide H-PTVTGAUG-OH. Similar to the case where methanol was the solvent, H 2 O adds to the electrophilic alkene center of 1a to form adduct 1c when water is the solvent (see Fig. 10) . In order to demonstrate that the presence of peptide H-PTVTGAUG-OH is required for the generation of 1a, we conducted a control experiment where dimedone was reacted with H 2 O 2 alone. A small amount of 1a is present in this control experiment as shown in the bottom panel of Figure 10 . However, during the course of this experiment, an unknown, contaminating selenium-containing compound, eluted from the column (identified by the characteristic isotope pattern of selenium). This contaminant is most likely present from previous exposure of the LCMS system to selenopeptides. We hypothesized that the excess H 2 O 2 injected into the LCMS reacted with this selenium-containing compound to generate a seleninic acid in situ during separation on the LC column, thereby generating 1a upon its reaction with dimedone. Further control experiments using 1 H NMR and direct-infusion ESI mass spectrometry provided evidence for this claim as no reaction between dimedone and H 2 O 2 was observed during Figure 8 . Proposed mechanism of the reaction of dimedone with seleninic acids. The elimination of a selenolate anion in the second-to-last step of the mechanism produces the dimeric dimedone species 1a. The selenolate anion is then immediately oxidized to the diselenide by dissolved O 2 to the more stable diselenide species. see Fig. S16 for direct-infusion ESI mass spectrometry control). Therefore, the selectivity of our proposed assay for seleninic acids is confirmed in that the generation of 1a occurs in neither the presence of H 2 O 2 nor sulfinic acids.
Discussion
As described in Figure 2 , here we have revisited the quandary of why mTrxR cannot be inhibited by dimedone, even though a Sec-selenenic acid, a strong electrophile, must be formed upon reaction of the enzyme with H 2 O 2. 8 Our curiosity led us to delve into this problem based on two key observations that are described in the following two sections.
Dimedone and Sec-selenenic acids
The first key observation came in the form of a literature search for the reported pK a value of the ahydrogens of dimedone, which we found to be 5.
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This low pK a renders dimedone a suitable leaving group in S N 2-like reactions. Further motivation was found in the form of multiple reports detailing the lability of both a-keto sulfides and selenides toward thiols and selenols. [22] [23] [24] [25] [26] [27] [28] The Sec-dimedone label comprises an a-diketo selenide, which we hypothesized would be even more labile than the reported amonoketo selenides. Coupled with the fact that C-Se bonds are weaker than C-S bonds due to their lower-lying r* orbital, 29 we thought that the Secdimedone bond might be labile to nucleophiles. This idea was supported by our initial experiment where we showed that the wild type mTrxR-GCUG enzyme retained full selenocystine reductase activity in the presence of H 2 O 2 and dimedone, whereas the mutant enzyme mTrxR-GGUG (no resolving Cys) only retained 74% of selenocystine reductase activity under the same conditions. However, it was still unclear whether the wild type enzyme was retaining activity due to the mechanism shown in Figure 2 (A) (resolution of Sec-selenenic acid by resolving Cys) or the mechanism in Figure 2 (B) (removal of dimedone label by resolving Cys).
To provide thorough evidence that the Secdimedone adduct is labile and that the mechanism shown in Figure 2(B) is plausible, we turned to a peptide model to facilitate our analysis. We explicitly chose to remove the resolving Cys residue from our model wild type, peptide H-PTVTGCUG-OH. The reason behind this was to eliminate the possibility of selenosulfide bond formation through the mechanism shown in Figure 2(A) . Reducing agents were added after the peptide was alkylated with dimedone to mimic the resolving Cys in the enzyme and the results show that, indeed, the Sec-dimedone bond is labile.
Possible mechanisms explaining the removal of the dimedone label on H-PTVTGAUG-OH are shown in Figure 11 . Whether bME [ Fig. 11(A) ], TCEP [ Fig.  11(B) ] or selenocystine/cystine [ Fig. 11(C) ] are used as removal reagents, the selenium atom of the Secdimedone adduct acts as the electrophile in mechanisms similar to the one shown in Figure 2 (B), except here exogenous nucleophiles are used instead of the resolving Cys residue of the peptide/enzyme. The 10-fold excess of bME and TCEP used in this experiment is conservative when considering the theoretical effective molarity of the adjacent, resolving Cys residue in the peptide/enzyme. [30] [31] [32] The surprising result that cystine (a disulfide compound) and selenocystine (a diselenide compound) were able to partially remove the Sec-dimedone label [ Fig.  11(C) ] demonstrates the lability of the Sec-dimedone adduct. An alternative mechanism to that shown in Figure 11 (C) can also be envisioned in which the selenide of the Sec-dimedone acts as nucleophile to attack an electrophilic disulfide (cystine) or diselenide (selenocystine). The use of a selenide as a nucleophile is not unprecedented. 33 Indeed, it is this characteristic of selenides that led to the development of a protecting group strategy that allows for the facile deprotection of Sec residues protected with the p-methoxybenzyl group by our lab. 34 While our data provide evidence that the mechanism shown in Figure 2 (B) may explain why the wild type mTrxR-GCUG enzyme is not inhibited by dimedone in the presence of H 2 O 2 , the data also demonstrate that dimedone may not be the most suitable molecular probe to identify Sec-selenenic acids in proteins. In a previous report, K. S. Carroll et al. showed that the dimedone label of a Cyscontaining dipeptide was stable over 12 h when exposed to reducing conditions of 103 DTT, TCEP, or GSH in potassium phosphate buffer, pH 7.4. 17 In a subsequent report, the authors studied the stability of linear, nucleophilic probes (designed to alkylate Cys-sulfenic acid) to similar reducing conditions. 35 Interestingly, they found that, for the most part, there was no direct correlation between leaving group potential (pK a ) and stability of the Cys-nucleophile label. The weaker C-Se bond relative to the C-S bond most likely renders the Secdimedone adduct inherently labile when compared to the Cys-dimedone adduct. Therefore, caution must be taken when attempting to use dimedone to alkylate Sec-selenenic acid. Any soft nucleophile, such as a thiol or phosphine, that is present during or after alkylation conditions has the ability to remove the Sec-dimedone label as shown in Figure 11 . Intracellular reducing agents such as GSH, or denaturing agents such as DTT, may cause removal of the Sec-dimedone label during in vivo and in vitro assays, respectively, potentially leading to false negatives. Last, special attention must be paid to enzymes that possess free Cys residues near the site of Sec-dimedone alkylation, as in the case with mTrxR and selenoprotein S. These Cys residues will interfere with Sec-selenenic acid alkylation by either (i) reducing the Sec-selenenic acid, resulting in a selenosulfide bond [ Fig. 2(A) ], or (ii) removing the dimedone label [ Fig. 2(B) ]. 
Dimedone and Sec-seleninic acids
Our second key observation, which led us to explore dimedone's reactivity toward seleninic acids, was the realization of the explicitly opposite nature of seleninic acids when compared to sulfinic acids. Sulfinic acids are widely known as reducing agents, whereas seleninic acids are considered weak oxidizing agents. 2, [36] [37] [38] The reducing (nucleophilic) property of sulfinic acids is exemplified when considering the nature of the molecular probe that was recently developed for Cys-sulfinic acids (NO-Bio): the probe is electrophilic and is the recipient of electrons from a Cys-sulfinic acid. 21 On the other hand, the highly oxidative (electrophilic) nature of seleninic acids allows them to be readily reduced by thiols and other, mild reducing agents such as ascorbate.
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Both PhSeO 2 H and MeSeO 2 H are inexpensive and commercially available and served us well as model compounds to investigate dimedone's reactivity toward seleninic acids. The results from our 77 Se NMR time course experiments and our LCMS experiments using PhSeO 2 H and MeSeO 2 H showed that these seleninic acids were being reduced to the corresponding diselenide compounds and, as a result, were oxidizing dimedone to the dimeric form 1a in the seleno-Pummerer reaction detailed in Figure 8 . We were initially disappointed that dimedone did not "tag" the model seleninic acids, forming a stable adduct that could be detected and used to identify a protein Sec-seleninic acid. However, the formation of 1a led us to pursue the development of a potential assay for Sec-seleninic acids. In the assay, 1a acts as a detectable chemical footprint indicating that a transient Sec-seleninic acid had formed when Sec was oxidized with H 2 O 2 . We had high confidence moving forward with the development with the knowledge that both sulfinic acids and H 2 O 2 itself are unreactive to dimedone, giving the potential assay high selectivity for Sec-seleninic acid.
The validity of the assay was confirmed during our experiments with model peptide H-PTVTGAUG-OH. In this case, the Sec-seleninic acids were generated in situ to mimic conditions that would occur in both in vitro and in vivo assays. We were able to detect the formation of 1a via LCMS after exposing the peptide H-PTVTGAUG-OH to a 5-molar excess of H 2 O 2 and a 2-molar excess of dimedone. A large excess of dimedone relative to peptide is not required for the formation of 1a, indicating reasonably fast reaction kinetics for assay viability. This report marks the first time a molecular probe has been used to identify the presence of a Sec-seleninic acid.
To date, the transient seleninic acid species has been detected only by 77 Se NMR, [42] [43] [44] [45] [46] [47] [48] X-ray crystallography, 47, [49] [50] [51] and mass spectrometry. 52, 53 However, these methods of detection are not ideal. 
Conclusions
This report has clearly demonstrated the differences in the chemical properties of Cys-sulfenic acid and Sec-selenenic acid toward alkylation by dimedone. A Cys-dimedone adduct is much more stable toward nucleophiles compared to a Sec-dimedone adduct, which is labile toward nucleophiles. The lability of the Sec-dimedone adduct is problematic for the detection of Sec-selenenic acids under in vivo conditions due to the presence of glutathione. Further differences between S-oxides and Se-oxides is demonstrated by the finding that Cys-sulfinic acid is unreactive toward dimedone, while Sec-seleninic acid reacts with dimedone to yield and a diselenide and a dimedone dimer, the latter forms as a result of the seleno-Pummerer reaction. The presence of the dimedone dimer may possibly be used in the future for the detection of transient Sec-seleninic acids in enzymes/proteins.
Materials and methods
General methods
Unless otherwise stated, all nonaqueous reactions were carried out in either oven-dried or flame-dried glassware. All commercially available starting materials were purchased from Aldrich, Fischer Scientific, or Acros Organics, and used as received. Analytical thin-layer chromatography (TLC) was performed on Millipore TLC Silica gel 60 F 254 silica gel plates with UV indicator. Visualization was accomplished by irradiation under a 254 nm UV lamp or stained with either an aqueous solution of ceric ammonium molybdate, potassium permanganate, or phosphomolybdic acid. Flash chromatography was performed using a forced flow of the indicated solvent system on silica gel (32-63 lm particle size). 
Production of thioredoxin reductase by semisynthesis
The wild type mTrxR-GCUG* enzyme and the mutant mTrxR-GGUG enzyme were produced by protein semisynthesis using well described methods published by our laboratory. 55 Attempt to inhibit thioredoxin reductase by dimedone treatment in presence of H 2 O 2
Wild type mTrxR-GCUG (10 nM) or mutant mTrxR-GGUG (50 nM), were incubated with 200 lM NADPH and 1 mM EDTA in 100 mM potassium phosphate buffer, pH 7.0 for 5 min. After 5 min, 500 lM dimedone or the same volume of methanol (control) was added to the reaction mixture along with 300 lM H 2 O 2 . The reactions were incubated for 25 min followed by the addition of catalase (170 nM) for 5 min to quench the H 2 O 2 . Enzyme activity was then initiated by the addition of 90 lM selenocystine, and enzyme activity was determined spectrophotometrically by following the consumption of NADPH at 340 nm.
Peptide synthesis
Peptides were synthesized as previously described using 2-chlorotritylchloride resin and standard Fmoc-solid phase peptide synthesis protocol. 55 Once synthesized, peptides were cleaved from the resin using a cocktail containing 96:2:2 trifluoroacetic acid (TFA), triisopropylsilane (TIS), H 2 O, and 2 equivalents of dithionitropyridine (DTNP). 34, 56 Following cleavage, the volume was reduced by evaporation under a stream of N 2 and peptide was precipitated using cold Et 2 O. Once dry, the peptides were suspended in H 2 O with minimal acetonitrile, frozen (2788C), lyophilized, and purified via preparatory HPLC. Peptide composition was analyzed using direct infusion APCI mass spectrometry.
Labeling of model Sec-containing peptides with dimedone
Peptides were synthesized with the Sec residue initially protected as the p-methoxybenzyl (Mob) derivative. The Mob group on Sec was replaced with a 5-nitro-2-pyridinesulfenyl (5-Npys) group by addition of DTNP to the cleavage cocktail. 56 Upon addition of DTNP, the Mob protecting group on Sec is replaced with 5-Npys. Attack by the adjacent Cys residue of the wild type peptide (H-PTVTGCUG-OH) onto the selenium atom of the Sec(5-Npys) group results in the rapid formation of an intramolecular selenosulfide bond. The oxidized, wild type peptide (5 lM) was reduced with 50 lM tris(2-carboxyethyl)phosphine (TCEP) in 100 mM potassium phosphate pH 7.0 for 15 min, followed by incubation with 50 lM or 500 lM dimedone and 5 lM H 2 O 2 at room temperature while being shaken at low speed for 25 min. The samples were then analyzed via LCMS.
As a control, the same peptide (5 lM) was reduced with 50 lM TCEP in 100 mM potassium phosphate buffer, pH 7.0 for 15 min. After, 10 mM iodoacetic acid was added and the reaction was shaken in the dark at room temperature for 25 min. The samples were then analyzed via LCMS.
In the mutant peptide, H-PTVTGAUG-OH, the Sec residue was protected as Sec(5-Npys), which in this form is less reactive toward oxidation. In order to generate a free selenol in situ, the 5-Npys protecting group was removed by addition of ascorbate in *Note: The wild type mammalian TrxR is abbreviated as mTrxR-GCUG to indicate the amino acid composition of the last four amino acids. Likewise, mutants of mTrxR are abbreviated as mTrxR-AA 1 AA 2 AA 3 AA 4 .
100 mM potassium phosphate pH 7.0 for 30 min at 378C as we have previously reported. 15 The ratio of ascorbate to peptide (0.9:1) was sub-stoichiometric to ensure that no ascorbate remained after deprotection that could potentially scavenge H 2 O 2 or reduce oxidized Sec species during the experiment. Following deprotection, the peptide (5 lM) was incubated with 50 lM dimedone and 5 lM H 2 O 2 at room temperature while being shaken at low speed for 25 min. The reactions were then analyzed using LCMS as described above.
Demonstrating the lability of the Sec-dimedone label
Peptides were labeled with dimedone as described above. Following the 25 min incubation with 50 lM dimedone and 5 lM H 2 O 2 , b-mercaptoethanol (bME, 103), TCEP (103), cystine (10003), or selenocystine (10003) were added to the reaction mixture. The reactions were incubated at room temperature for 15 min while being shaken at low speed then analyzed via LCMS. 3 OH was made and the reaction was allowed to proceed with stirring for 48 h at room temperature. An aliquot of the reaction mixture was taken and analyzed via LCMS as described above.
Attempt to purify dimedone byproducts of reaction between dimedone and PhSeO 2 H Dimedone (280.4 mg, 2 mmol) was dissolved in methanol (10 mL) and benzeneseleninic acid (189.1 mg, 1 mmol) was added. The reaction was stirred at room temperature for 48 h. The solvent was evaporated and the crude mixture was purified via flash chromatography (SiO 2 ; 4:1 ethyl acetate/ dichloromethane) to yield 2 (see Fig. 9 ) as a white, crystalline solid, which was the only product able to be isolated. The 5-Npys protecting group of H-PTVTGAU(5-Npys)G-OH (1 mM) was removed by incubation with ascorbate at a ratio of 0.9:1 ascorbate:peptide in 100 mM potassium phosphate pH 7.0 for 30 min at 378C as described above. Following deprotection, the peptide was incubated with 2 mM dimedone and 5 mM H 2 O 2 for 25 min at room temperature while being shaken at low speed, after which the samples were analyzed via LCMS.
